| ECEAX | GWPDX | ECEAX / GWPDX | |
| Total Expense Ratio | 1.94 | 0.38 | 511% |
| Annual Report Gross Expense Ratio | 2.46 | 0.38 | 647% |
| Fund Existence | 24 years | 9 years | - |
| Gain YTD | 10.539 | 19.552 | 54% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 865M | 24.9B | 3% |
| Annual Yield % from dividends | 0.00 | 0.64 | - |
| Returns for 1 year | 5.34 | 10.63 | 50% |
| Returns for 3 years | 45.74 | 50.33 | 91% |
| Returns for 5 years | 51.02 | 34.57 | 148% |
| Returns for 10 years | 118.61 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NACP | 49.42 | 0.45 | +0.91% |
| Impact Shares NAACP Minority Empwrmt ETF | |||
| GDEC | 37.40 | 0.03 | +0.09% |
| FT Vest U.S. Eq Mod Buffr ETF - Dec | |||
| VNIE | 24.20 | N/A | N/A |
| Vontobel International Equity Active ETF | |||
| PSQO | 20.78 | -0.03 | -0.12% |
| Palmer Square Credit Opportunities ETF | |||
| ARKG | 29.76 | -0.09 | -0.30% |
| ARK Genomic Revolution ETF | |||